[Metastatic malignant pancreatic tumor. Disappearance of symptoms 6 months after streptozotocin treatment (author's transl)].
D007516:Adenoma, Islet Cell / Q000188:drug therapy* / Q000601:surgery; D003981:Diazoxide / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005665:Furosemide / Q000009:adverse effects / Q000627:therapeutic use; D006628:Hirsutism / Q000139:chemically induced; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000601:surgery; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000601:surgery; D013311:Streptozocin / Q000627:therapeutic use*
D013311:Streptozocin; D005665:Furosemide; D003981:Diazoxide
Nésidioblastome malin métastasé. Disparition de tout symptôme 6 mois après un traitement par la streptozotocine.